Multiple Sclerosis Information
View Article  Mitoxandrone - Leukemia Risk
Patients with multiple sclerosis who are treated with a cumulative dose of 82 mg/m[2 of Mitoxandrone (MTX) are at a 2.7 higher risk of developing acute leukemia (AL), according to a late-breaking abstract presented on April 30   more »
View Article  Mitoxantrone (Novantrone)
Mitoxantrone (mye-toe-ZAN-trone) belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancer. It is also used to treat some forms of multiple sclerosis (MS). This medicine    more »
View Article  ALERT: Mitoxantrone (Novantrone) – heart problems
FDA is informing health care professionals about additional recommendations for cardiac monitoring and reminding of the importance of monitoring cardiac function in patients with multiple sclerosis (MS) who are treated with mitoxantrone.   more »
View Article  Mitoxantrone in MS Show Good Safety and Tolerability
Five-year cardiac and haematological data from a large cohort of multiple sclerosis (MS) patients show that mitoxantrone is generally well tolerated and safe. The results on mitoxantrone, which is routinely used in   more »
View Article  Mitoxantrone - Drug Information
Mitoxantrone (mye-toe-ZAN-trone) belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancer. It is also used to treat some forms of multiple sclerosis (MS). This medicine will not cure MS, but   more »